Factory at center of baby formula recall will produce Similac again soon

Factory at center of baby formula recall will produce similac soon

Roughly six months after it shut down its baby formula plant in Michigan, Abbott Laboratories said it plans to begin making Similac again.

The will be the latest to restart production after Abbott's specialty formulas, including EleCare, resumed production a couple of months ago. In February, Abbott closed its plant and recalled some amid concerns from the U.S. Food and Drug Administration about bacterial contamination.

"We estimate that it will take about six weeks for the product to begin shipping to retail locations as it enters into production, enhanced pre- and post-production testing, and cycles through shipping and retail distribution networks," Abbott chairman and CEO Robert Ford said in a statement issued Friday.

Unfortunately, the plant shutdown exacerbated first triggered by supply chain disruption due to the pandemic.

"We know that the nationwide infant formula shortage has been difficult for the families we serve, and while restarting Similac production in Michigan is an important milestone, we won't rest until this product is back on shelves," Ford said.

Though the recall came after two infants died and two others became ill, the company said there is no evidence linking its products to those incidents.

However, the company does plan to enhance its plant to prevent shutdowns while pledging to keep bacteria out of the Sturgis facility.

"We have a zero-tolerance policy for Cronobacter or any pathogen in our plants," Abbott said. Temporary stoppages may occur to deal with future issues, according to the company, which noted that it will have stocked retail shelves with 8 million pounds of formula in August.

The formula shortage was blamed, in part, on U.S. reliance on only a few manufacturers. It led to changes, including relaxed enforcement for importing formula from other countries and shipping supplies from abroad via military plane.

President Joe Biden also invoked the Defense Production Act to help boost supplies of infant formula.

More information: The U.S. Centers for Disease Control and Prevention has more on Cronobacter.

Copyright © 2022 HealthDay. All rights reserved.

Citation: Factory at center of baby formula recall will produce Similac again soon (2022, August 29) retrieved 7 December 2022 from https://medicalxpress.com/news/2022-08-factory-center-baby-formula-recall.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Troubled infant formula plant resumes production

4 shares

Feedback to editors